Navigation Links
Rare Womens Lung Disease May Yield Insights Into Common Diseases

For many decades, medical research studies focused primarily on men and the results of countless studies were then applied to women. But we now know that the biological sex and gender differences between men and women are more than skin deep. Beginning in 1990, the Society for Womens Health Research, a Washington, D.C., based advocacy organization, conveyed to a national audience the need for including women in biomedical research studies. Today, research on women is robust.

Biomedical research can make an enormous difference in the lives of women. Take Dr. Elizabeth Petri Henske, M.D., the recipient of the 2007 Society for Womens Health Research Medtronic Prize for Scientific Contributions to Womens Health. The prize was established to recognize a women scientist or engineer for her contributions to womens health and encourage women to work on issues uniquely related to womens health.

Henske is an oncologist at the Fox Chase Cancer Center in Philadelphia, Pa. Her work focuses on the genetic and cellular mechanisms leading to two diseases not well-known to the public: tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM).

LAM is a lung disease that almost exclusively affects young women. LAM has a stronger female predisposition than lupus or breast cancer, and may have the strongest biological sex predisposition of any human disease, except for diseases of the genital organs, and it is often fatal. Scientists estimate that there could be as many as 250,000 LAM patients worldwide.

LAM affects young women, and can strike suddenly during pregnancy, Henske said. LAM causes the lungs to fill with abnormal cells. As a result, cysts or holes can develop in the lung, causing it to collapse. The disease takes a major toll on the body, making even mundane tasks difficult. Women with LAM often need oxygen, are continuously short of breath, and are unable care for their children or walk up a flight of stairs , Henske said. Many women with LAM die prematurely.

As part of her work, Henske discovered that mutations in the tuberous sclerosis gene, which triggers TSC, a genetic disorder that causes tumors to form in many different organs, including the brain, eyes, heart, kidney, skin and lungs, plays a role in the cause of LAM. Her current work involves looking into the role female hormones play in the growth and metastasis of LAM cells.

Her tireless efforts have shed light on the connection between two diseases, provided understanding of the underlying mechanisms and hopefully will one day lead to a cure. By studying LAM we hope to develop treatments to eradicate LAM cells, and also learn more about how hormones cause abnormal cells to grow and metastasize, Henske said.

Henskes work may also benefit research on common diseases because the cellular pathways that are activated in tuberous sclerosis and LAM are also activated in many forms of cancer, and in diabetes and obesity. What is learned about LAM may help us understand more common diseases in which hormones play an important role, such as breast cancer. The impact of LAM research could spread to other diseases that are not hormonally dependent, she points out.

Despite the current advances being made by researchers like Henske, there is still an enormous amount that we do not yet understand about sex and gender differences in health and disease, ground that will hopefully be covered by researchers in the future.


'"/>




Related medicine news :

1. Cosmetic Genital Surgery may Be Fuelling Womens Insecurity About Their Bodies
2. Diabetic Womens Death Rate Shows No Decline
3. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
4. Vitamins-The answer to Heart Disease?
5. Link between Constipation and Parkinsons Disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. New Drug PP188 Helps Sickle Cell Disease
8. Gene Treatment for Heart Disease
9. Legume Consumption Can Cut Heart Disease Risk
10. Link Between Infection And Heart Disease
11. Celiac Disease in Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... 30, 2017 , ... This morning, more than 275 medical ... support for an independent Vaccine Safety Commission. Five of the signers of the ... hold a press conference at 9:00 AM Friday, March 31 at the ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an Atlanta-based dog ... Protect Law that assists dog owners in creating legally-enforceable pet trusts for their ... the natural next step to protect their new companion. Says Evan Dunbar, CEO of ...
(Date:3/29/2017)... ... 2017 , ... Sports Brand EXOUS Bodygear announced today a special sale price ... the remaining days of March, the price will be only $19.97. The EXOUS Bodygear ... just $10 (regular retail price $19.97). , The special promotional prices are to help ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... FASTBRACES® in Carnegie, OK, from Dr. Jamie Cameron, with or without ... efficiently, compared to traditional orthodontic treatment. Depending on each patient’s case, treatment with ...
(Date:3/29/2017)... ... ... Curio Wellness , a premium medical cannabis brand and trusted healthcare ... team with prominent executives from both inside and outside the cannabis industry. , ... Dumbauld , who has more than twenty years of business leadership and investment experience ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... TOKYO , March 29, 2017  The ... unique Japanese public-private partnership formed to battle infectious ... investments totaling US$23 million* that could help deliver ... host of debilitating conditions. This ... a Phase 3 clinical trial testing a pediatric ...
(Date:3/29/2017)... leader in accelerated orthodontics, OrthoAccel ® Technologies, Inc. ... Manal Ibrahim , Kenji Ojima , Ivan ... microlecture presenters at the AcceleDent ® booth (#3037) ... Session, April 21-25, 2017. Orthodontists and their staff are ... a.m. On the opening morning of AAO exhibitions, Sat., ...
(Date:3/29/2017)... 2017 Transparency Market Research ... an exhaustive study of the U.S. substance abuse treatment ... are functional in this market at present, making ... companies, such as GlaxoSmithKline Plc., Pfizer Inc., Alkermes ... various marketing strategies to increase their visibility, the ...
Breaking Medicine Technology: